Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease

R Loomba, VWS Wong - Alimentary pharmacology & …, 2024 - Wiley Online Library
Summary Background The American and European liver associations have endorsed new
nomenclature of steatotic liver disease (SLD) and definition of metabolic dysfunction …

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

ZM Younossi, SA Alqahtani, K Alswat, Y Yilmaz… - Journal of …, 2024 - Elsevier
Background & Aims Patients with fatty liver disease may experience stigma from the disease
or comorbidities. In this cross-sectional study, we aimed to understand stigma among …

THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 …

ZM Younossi, P Golabi, JK Price, S Owrangi… - Clinical …, 2024 - Elsevier
Background and aims Nonalcoholic fatty liver disease (NAFLD) now known as metabolic
dysfunction associated steatotic liver disease (MASLD) is closely associated with type 2 …

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

R Loomba, ML Hartman, EJ Lawitz… - … England Journal of …, 2024 - Mass Medical Soc
Background Metabolic dysfunction–associated steatohepatitis (MASH) is a progressive liver
disease associated with liver-related complications and death. The efficacy and safety of …

ONOO–-activatable and LD-traced NIR fluorescent probe for mechanism study and early diagnosis of NAFLD and diabetes induced liver injury

N Wang, X Lu, J Wang, R Han, X Ma, B Zhang… - Sensors and Actuators B …, 2024 - Elsevier
Lipid metabolism disorder and oxidative stress play an essential role in the occurrence and
development of metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and …

Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States

S Gawrieh, E Vilar‐Gomez, TA Woreta… - Alimentary …, 2024 - Wiley Online Library
Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) has recently
been proposed as a replacement term for NAFLD. Aims To assess the effects of this new …

Clinical classification of obesity and implications for metabolic dysfunction-associated fatty liver disease and treatment

Y Ding, Q Deng, M Yang, H Niu, Z Wang… - … Syndrome and Obesity, 2023 - Taylor & Francis
Obesity, and metabolic dysfunction-associated fatty liver disease (MAFLD) have reached
epidemic proportions globally. Obesity and MAFLD frequently coexist and act synergistically …

Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

A Csermely, A Mantovani, ML Morieri, L Palmisano… - Diabetes & …, 2023 - Elsevier
Aim We examined whether different insulin administration modalities, ie, multiple daily
injections (MDI) or continuous subcutaneous insulin infusion (CSII by insulin pumps), are …

[HTML][HTML] Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD …

LJ Dobbie, J Burgess, A Hamid, SJ Nevitt, TJ Hydes… - Nutrients, 2024 - mdpi.com
Introduction: Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD) is a
common cause of chronic liver disease. This review assessed the efficacy of a Low-Calorie …

[HTML][HTML] EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

F Tacke, P Horn, VWS Wong, V Ratziu, E Bugianesi… - Journal of …, 2024 - Elsevier
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …